Cargando…

Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines

Mitochondrial dysfunction promotes cancer aggressiveness, metastasis, and resistance to therapy. Similar traits are associated with epithelial mesenchymal transition (EMT). We questioned whether mitochondrial dysfunction induces EMT in head and neck cancer (HNC) cell lines. We induced mitochondrial...

Descripción completa

Detalles Bibliográficos
Autores principales: Greier, Maria Carmo, Runge, Annette, Dudas, Jozsef, Pider, Viktoria, Skvortsova, Ira-Ida, Savic, Dragana, Riechelmann, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345891/
https://www.ncbi.nlm.nih.gov/pubmed/35918485
http://dx.doi.org/10.1038/s41598-022-16829-5
_version_ 1784761530708918272
author Greier, Maria Carmo
Runge, Annette
Dudas, Jozsef
Pider, Viktoria
Skvortsova, Ira-Ida
Savic, Dragana
Riechelmann, Herbert
author_facet Greier, Maria Carmo
Runge, Annette
Dudas, Jozsef
Pider, Viktoria
Skvortsova, Ira-Ida
Savic, Dragana
Riechelmann, Herbert
author_sort Greier, Maria Carmo
collection PubMed
description Mitochondrial dysfunction promotes cancer aggressiveness, metastasis, and resistance to therapy. Similar traits are associated with epithelial mesenchymal transition (EMT). We questioned whether mitochondrial dysfunction induces EMT in head and neck cancer (HNC) cell lines. We induced mitochondrial dysfunction in four HNC cell lines with carbonyl cyanide-4(trifluoromethoxy)phenylhydrazone (FCCP), a mitochondrial electron transport chain uncoupling agent, and oligomycin, a mitochondrial ATP synthase inhibitor. Extracellular flux analyses and expression of the cystine/glutamate antiporter system xc (xCT) served to confirm mitochondrial dysfunction. Expression of the EMT-related transcription factor SNAI2, the mesenchymal marker vimentin and vimentin/cytokeratin double positivity served to detect EMT. In addition, holotomographic microscopy was used to search for morphological features of EMT. Extracellular flux analysis and xCT expression confirmed that FCCP/oligomycin induced mitochondrial dysfunction in all cell lines. Across the four cell lines, mitochondrial dysfunction resulted in an increase in relative SNAI2 expression from 8.5 ± 0.8 to 12.0 ± 1.1 (mean ± SEM; p = 0.007). This effect was predominantly caused by the CAL 27 cell line (increase from 2.2 ± 0.4 to 5.5 ± 1.0; p < 0.001). Similarly, only in CAL 27 cells vimentin expression increased from 2.2 ± 0.5 × 10(–3) to 33.2 ± 10.2 × 10(–3) (p = 0.002) and vimentin/cytokeratin double positive cells increased from 34.7 ± 5.1 to 67.5 ± 9.8% (p = 0.003), while the other 3 cell lines did not respond with EMT (all p > 0.1). Across all cell lines, FCCP/oligomycin had no effect on EMT characteristics in holotomographic microscopy. Mitochondrial dysfunction induced EMT in 1 of 4 HNC cell lines. Given the heterogeneity of HNC, mitochondrial dysfunction may be sporadically induced by EMT, but EMT does not explain the tumor promoting effects of mitochondrial dysfunction in general.
format Online
Article
Text
id pubmed-9345891
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93458912022-08-04 Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines Greier, Maria Carmo Runge, Annette Dudas, Jozsef Pider, Viktoria Skvortsova, Ira-Ida Savic, Dragana Riechelmann, Herbert Sci Rep Article Mitochondrial dysfunction promotes cancer aggressiveness, metastasis, and resistance to therapy. Similar traits are associated with epithelial mesenchymal transition (EMT). We questioned whether mitochondrial dysfunction induces EMT in head and neck cancer (HNC) cell lines. We induced mitochondrial dysfunction in four HNC cell lines with carbonyl cyanide-4(trifluoromethoxy)phenylhydrazone (FCCP), a mitochondrial electron transport chain uncoupling agent, and oligomycin, a mitochondrial ATP synthase inhibitor. Extracellular flux analyses and expression of the cystine/glutamate antiporter system xc (xCT) served to confirm mitochondrial dysfunction. Expression of the EMT-related transcription factor SNAI2, the mesenchymal marker vimentin and vimentin/cytokeratin double positivity served to detect EMT. In addition, holotomographic microscopy was used to search for morphological features of EMT. Extracellular flux analysis and xCT expression confirmed that FCCP/oligomycin induced mitochondrial dysfunction in all cell lines. Across the four cell lines, mitochondrial dysfunction resulted in an increase in relative SNAI2 expression from 8.5 ± 0.8 to 12.0 ± 1.1 (mean ± SEM; p = 0.007). This effect was predominantly caused by the CAL 27 cell line (increase from 2.2 ± 0.4 to 5.5 ± 1.0; p < 0.001). Similarly, only in CAL 27 cells vimentin expression increased from 2.2 ± 0.5 × 10(–3) to 33.2 ± 10.2 × 10(–3) (p = 0.002) and vimentin/cytokeratin double positive cells increased from 34.7 ± 5.1 to 67.5 ± 9.8% (p = 0.003), while the other 3 cell lines did not respond with EMT (all p > 0.1). Across all cell lines, FCCP/oligomycin had no effect on EMT characteristics in holotomographic microscopy. Mitochondrial dysfunction induced EMT in 1 of 4 HNC cell lines. Given the heterogeneity of HNC, mitochondrial dysfunction may be sporadically induced by EMT, but EMT does not explain the tumor promoting effects of mitochondrial dysfunction in general. Nature Publishing Group UK 2022-08-02 /pmc/articles/PMC9345891/ /pubmed/35918485 http://dx.doi.org/10.1038/s41598-022-16829-5 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Greier, Maria Carmo
Runge, Annette
Dudas, Jozsef
Pider, Viktoria
Skvortsova, Ira-Ida
Savic, Dragana
Riechelmann, Herbert
Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
title Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
title_full Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
title_fullStr Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
title_full_unstemmed Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
title_short Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
title_sort mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345891/
https://www.ncbi.nlm.nih.gov/pubmed/35918485
http://dx.doi.org/10.1038/s41598-022-16829-5
work_keys_str_mv AT greiermariacarmo mitochondrialdysfunctionandepithelialtomesenchymaltransitioninheadneckcancercelllines
AT rungeannette mitochondrialdysfunctionandepithelialtomesenchymaltransitioninheadneckcancercelllines
AT dudasjozsef mitochondrialdysfunctionandepithelialtomesenchymaltransitioninheadneckcancercelllines
AT piderviktoria mitochondrialdysfunctionandepithelialtomesenchymaltransitioninheadneckcancercelllines
AT skvortsovairaida mitochondrialdysfunctionandepithelialtomesenchymaltransitioninheadneckcancercelllines
AT savicdragana mitochondrialdysfunctionandepithelialtomesenchymaltransitioninheadneckcancercelllines
AT riechelmannherbert mitochondrialdysfunctionandepithelialtomesenchymaltransitioninheadneckcancercelllines